So! Money doesn't really make the world go round, but it sure greases the skids in late capitalism. Take Mylan's EpiPen, which has parents and lawmakers up in arms. The injection is meant to halt anaphylactic shock in patients who may have encountered an allergen — so it's a crucial buy for a lot of people in back-to-school season. But its price has been steadily rising since 2007, when it was a little more than $100. Now a package of two pens retails for $609, and most of that price hike came in the last few years. Liz talks about pharmaceutical pricing, and why what Mylan's doing is standard-issue for the industry — right down to that expanded assistance program. Maybe it's time we stopped talking about individual expensive drugs and...
Verge ESP: Let's talk money
Continue Reading
Bagikan Berita Ini
0 Response to "Verge ESP: Let's talk money"
Post a Comment